Advicenne Announces 51% Growth in Sibnayal® Gross Sales in H1 2023 to almost €1.0 Million

Advicenne first-half 2023 gross sales1 up 23% to 2.2 million eurosSales of Sibnayal® (potassium citrate/potassium hydrogen carbonate) up 128% in volume termsSibnayal® becomes the Group's leading sales contributorPARIS--(BUSINESS WIRE)--Regulatory News:Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a special...

Related Keywords

Canada ,France ,Denmark ,United Kingdom ,Paris ,France General ,Milan ,Lombardia ,Italy ,Germany ,French ,Didier Laurens ,Advicenne Euronext ,Health Administrations ,European Renal Association ,Health Administration ,Regulatory News ,Euronext Growth Paris ,Chief Executive Officer ,Eastern European ,Middle East ,Marketing Approval ,Euronext Paris ,Registration Document ,